Barclays Updates 2026 View on Life Insurers, Lowers RGA Price Target

Reinsurance Group of America, Incorporated (NYSE:RGA) is included among the 14 Best Mid Cap Dividend Aristocrat Stocks to Buy Now.

On January 8, Barclays reduced its price target on Reinsurance Group of America, Incorporated (NYSE:RGA) to $237 from $251, while still maintaining an Overweight rating. The firm said it is heading into 2026 feeling “cautiously optimistic” about the life insurance space. Barclays believes the group’s strong capital levels, steady cash generation, and ongoing consolidation activity can help offset pressure from spread compression and higher tech-related spending. The target change was part of Barclays’ broader 2026 outlook refresh.

In other news, in October, RGA announced a strategic investment in FoxPath Capital Partners, a New York-based credit secondaries specialist. The company also made a multi-fund anchor commitment to the firm. RGA said the move gives it greater access to high-quality private assets in the expanding credit secondary market, while also improving portfolio flexibility and creating additional long-term investment opportunities.

Reinsurance Group of America, Incorporated (NYSE:RGA) is a global leader in life and health reinsurance, offering solutions that help clients manage risk and optimize capital.

While we acknowledge the potential of RGA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 12 Best Dow Stocks to Buy in 2026 and 13 Best Consumer Staples Dividend Stocks to Invest In Now

Disclosure: None.